Open label, pilot phase II study of Glivec in children and adolescents with life threatening diseases known to be associated with one or more Glivec-sensitive tyrosine kinases
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2013
At a glance
- Drugs Imatinib (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 29 Oct 2005 New trial record.